EVALUATION OF ANTI-PARKINSON DRUGS ON RESERPINE-INDUCED RIGIDITY IN RATS

被引:50
|
作者
GOLDSTEIN, JM [1 ]
BARNETT, A [1 ]
MALICK, JB [1 ]
机构
[1] SCHERING CORP,DEPT PHARMACOL,BLOOMFIELD,NJ 07003
关键词
D O I
10.1016/0014-2999(75)90154-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:183 / 188
页数:6
相关论文
共 50 条
  • [21] Effect of Tetramethylpyrazine on Reserpine-Induced Gastric Lesion in Rats
    Jun-Li Wan
    Chang-Liu Wang
    Qin-De Chang
    Digestive Diseases and Sciences, 1998, 43 : 1652 - 1656
  • [22] REVERSAL BY SEROTONERGIC AGENTS OF RESERPINE-INDUCED HYPERALGESIA IN RATS
    KULKARNI, SK
    ROBERT, RK
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 83 (3-4) : 325 - 328
  • [23] GASTRIC MOVEMENT OBSERVED IN RATS WITH RESERPINE-INDUCED ULCER
    KAGOSHIMA, M
    SUGURO, N
    FOLIA PHARMACOLOGICA JAPONICA, 1980, 76 (04) : P142 - P143
  • [24] RESERPINE-INDUCED RELEASE OF DRUGS FROM SYMPATHETIC NERVE ENDINGS
    CHANG, CC
    COSTA, E
    BRODIE, BB
    LIFE SCIENCES, 1964, 3 (08) : 839 - 844
  • [25] METABOLISM OF ANTI-PARKINSON DRUGS - EXAMPLE OF COMPETITIVE HYDROXYLATION
    STOCK, B
    SPITELLER, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1979, 29-1 (04): : 610 - 615
  • [26] ANTIPARKINSONIAN ACTION OF MK-801 ON THE RESERPINE-INDUCED RIGIDITY - A MECHANOMYOGRAPHIC ANALYSIS
    OSSOWSKA, K
    LORENCKOCI, E
    WOLFARTH, S
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1994, 7 (02) : 143 - 152
  • [27] Fracture Risk Associated with Parkinsonism and Anti-Parkinson Drugs
    Peter Vestergaard
    Lars Rejnmark
    Leif Mosekilde
    Calcified Tissue International, 2007, 81 : 153 - 161
  • [28] POTENTIAL ANTI-PARKINSON DRUGS DESIGNED BY RECEPTOR MAPPING
    MARTIN, YC
    JARBOE, CH
    KRAUSE, RA
    LYNN, KR
    DUNNIGAN, D
    HOLLAND, JB
    JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (02) : 147 - 150
  • [29] Fracture risk associated with parkinsonism and anti-parkinson drugs
    Vestergaard, Peter
    Rejnmark, Lars
    Mosekilde, Leif
    CALCIFIED TISSUE INTERNATIONAL, 2007, 81 (03) : 153 - 161
  • [30] Anti-Parkinson's disease drugs and pharmacogenetic considerations
    Agundez, Jose A. G.
    Garcia-Martin, Elena
    Alonso-Navarro, Hortensia
    Javier Jimenez-Jimenez, Felix
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (07) : 859 - 874